Acute fish oil and soy isoflavone supplementation increase postprandial serum (n-3) polyunsaturated fatty acids and isoflavones but do not affect triacylglycerols or biomarkers of oxidative stress in overweight and obese hypertriglyceridemic men

Journal of Nutrition

Volumn 139, Issue 6, 2009, Pages 1128-1134

  Hanwell, Heather E C ^a   Kay, Colin D ^b   Lampe, Johanna W ^c   Holub, Bruce J ^a   Duncan, Alison M ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FISH OIL; ISOFLAVONE; LIPID HYDROPEROXIDE; NOVASOY; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; POLYURETHAN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FATTY ACID BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; OXIDATIVE STRESS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL;

BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; HYPERTRIGLYCERIDEMIA; ISOFLAVONES; MALE; MIDDLE AGED; OVERWEIGHT; OXIDATIVE STRESS; POSTPRANDIAL PERIOD; SOYBEANS; TRIGLYCERIDES;

EID: 66749160867     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.105171     Document Type: Article

References (68)

1. Holub BJ. Clinical nutrition. 4. Omega-3 fatty acids in cardiovascular care. CMAJ. 2002;166:608-615
2. Lichtenstein AH. Soy protein, isoflavones and cardiovascular disease risk. J Nutr. 1998;128:1589-1592 (Pubitemid 28452838)
3. Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr. 2008;87:S1981-90.
4. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med. 1999;246:341-355 (Pubitemid 29479916)
5. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Despres JP. Postprandial triglyceride response in visceral obesity in men. Diabetes. 1998;47:953-960
6. Cohen JC, Noakes TD, Benade AJ. Serum triglyceride responses to fatty meals: effects of meal fat content. Am J Clin Nutr. 1988;47:825-827 (Pubitemid 18133806)
7. Harris WS, Connor WE, Alam N, Illingworth DR. Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res. 1988;29:1451-1460 (Pubitemid 19013039)
8. Westphal S, Orth M, Ambrosch A, Osmundsen K, Luley C. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids. Am J Clin Nutr. 2000;71:914-920 (Pubitemid 30176573)
9. Callow J, Summers LK, Bradshaw H, Frayn KN. Changes in LDL particle composition after the consumption of meals containing different amounts and types of fat. Am J Clin Nutr. 2002;76:345-350 (Pubitemid 34804055)
10. Ursini F, Zamburlini A, Cazzolato G, Maiorino M, Bon GB, Sevanian A. Postprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosis. Free Radic Biol Med. 1998;25:250-252 (Pubitemid 28293161)
11. Ursini F, Sevanian A. Postprandial oxidative stress. Biol Chem. 2002;383:599-605. (Pubitemid 34506297)
12. Kay CD, Holub BJ. The postprandial effects of dietary antioxidants in humans. Curr Atheroscler Rep. 2003;5:452-458 (Pubitemid 38906742)
13. Kelley DS, Siegel D, Vemuri M, Mackey BE. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr. 2007;86:324-333 (Pubitemid 47256914)
14. Qi K, Fan C, Jiang J, Zhu H, Jiao H, Meng Q, Deckelbaum RJ. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin Nutr. 2008;27:424-430
15. McLaughlin J, Middaugh J, Boudreau D, Malcom G, Parry S, Tracy R, Newman W. Adipose tissue triglyceride fatty acids and atherosclerosis in Alaska Natives and non-Natives. Atherosclerosis. 2005;181:353-362 (Pubitemid 41019617)
16. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort 1. Circulation. 2006;113:195-202. (Pubitemid 43754375)
17. Mozaffarian D. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr. 2008;87:S1991-6.
18. Brown JE, Wahle KW. Effect of fish-oil and vitamin E supplementation on lipid peroxidation and whole-blood aggregation in man. Clin Chim Acta. 1990;193:147-156
19. Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr. 2003;77:783-795
20. Grundt H, Nilsen DW, Mansoor MA, Nordoy A. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. Eur J Clin Nutr. 2003;57:793-800. (Pubitemid 36789992)
21. Spiteller G. Linoleic acid peroxidation: the dominant lipid peroxidation process in low density lipoprotein-and its relationship to chronic diseases. Chem Phys Lipids. 1998;95:105-162 (Pubitemid 28522220)
22. Dimitrova-Sumkovska J, Dosic-Markovska B, Zafirova-Roganovic D, Anastasovska V. Effects of different dietary fatty acid supplements upon lipoprotein metabolism and lipid peroxides production in hyperlipidemic rats. Prilozi. 2006;27:67-86.
23. Allard JP, Kurian R, Aghdassi E, Muggli R, Royall D. Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids. 1997;32:535-541 (Pubitemid 27213324)
24. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res. 1999;13:601-608 (Pubitemid 29520939)
25. Hwang J, Sevanian A, Hodis HN, Ursini F. Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid. Free Radic Biol Med. 2000;29:79-89. (Pubitemid 30658140)
26. Rohrdanz E, Ohler S, Tran-Thi QH, Kahl R. The phytoestrogen daidzein affects the antioxidant enzyme system of rat hepatoma H4IIE cells. J Nutr. 2002;132:370-375 (Pubitemid 34208735)
27. Anbazhagan V, Kalaiselvan A, Jaccob M, Venuvanalingam P, Renganathan R. Investigations on the fluorescence quenching of 2,3-diazabicyclo [2.2.2]oct-2-ene by certain flavonoids. J Photochem Photobiol B. 2008;91:143-150
28. Hodgson JM, Croft KD, Puddey IB, Mori TA, Beilin LJ. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J Nutr Biochem. 1996;7:664-669 (Pubitemid 27019422)
29. Rimbach G, De Pascual-Teresa S, Ewins BA, Matsugo S, Uchida Y, Minihane AM, Turner R, VafeiAdou K, Weinberg PD. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica. 2003;33:913-925 (Pubitemid 37255402)
30. Liu J, Chang SK, Wiesenborn D. Antioxidant properties of soybean isoflavone extract and tofu in vitro and in vivo. J Agric Food Chem. 2005;53:2333-2340 (Pubitemid 40395813)
31. Oh HY, Lim S, Lee JM, Kim DY, Ann ES, Yoon S. A combination of soy isoflavone supplementation and exercise improves lipid profiles and protects antioxidant defense-systems against exercise-induced oxidative stress in ovariectomized rats. Biofactors. 2007;29:175-185
32. Aoki H, Otaka Y, Igarashi K, Takenaka A. Soy protein reduces paraquat-induced oxidative stress in rats. J Nutr. 2002;132:2258-2262 (Pubitemid 34851660)
33. Park E, Shin JI, Park OJ, Kang MH. Soy isoflavone supplementation alleviates oxidative stress and improves systolic blood pressure in male spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 2005;51:254-259 (Pubitemid 41355261)
34. Djuric Z, Chen G, Doerge DR, Heilbrun LK, Kucuk O. Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett. 2001;172:1-6. (Pubitemid 32823466)
35. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, et al. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr. 2002;76:365-372 (Pubitemid 34804058)
36. Jenkins DJ, Kendall CW, Vidgen E, Vuksan V, Jackson CJ, Augustin LS, Lee B, Garsetti M, Agarwal S, et al. Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism. 2000;49:1496-1500
37. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA. 1998;95:3106-3110 (Pubitemid 28135862)
38. Nhan S, Anderson KE, Nagamani M, Grady JJ, Lu LJ. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women. Nutr Cancer. 2005;53:73-81. (Pubitemid 43071211)
39. Wiseman H, O'Reilly JD, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR, Sanders TA. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr. 2000;72:395-400.
40. Kampkotter A, Wiegand C, Timpel C, Rohrdanz E, Chovolou Y, Kahl R, Watjen W. Increased expression of catalase in human hepatoma cells by the soy isoflavone, daidzein. Basic Clin Pharmacol Toxicol. 2008;102:437-442
41. Banz W, Hauck S, Gename B, Winters T, Bartke A. Soy isoflavones modify liver free radical scavenger systems and liver parameters in Sprague-Dawley rats. J Med Food. 2004;7:477-481 (Pubitemid 40095850)
42. Mahn K, Borras C, Knock GA, Taylor P, Khan IY, Sugden D, Poston L, Ward JP, Sharpe RM, et al. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J. 2005;19:1755-1757 (Pubitemid 41429553)
43. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, Vina J. Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. FASEB J. 2006;20:2136-2138
44. Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006;79:1578-1584 (Pubitemid 44301276)
45. Raschke M, Rowland IR, Magee PJ, Pool-Zobel BL. Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress. Carcinogenesis. 2006;27:2322-2330 (Pubitemid 44644823)
46. Oh HY, Kim SS, Chung HY, Yoon S. Isoflavone supplements exert hormonal and antioxidant effects in postmenopausal Korean women with diabetic retinopathy. J Med Food. 2005;8:1-7. (Pubitemid 40626786)
47. DiSilvestro RA, Goodman J, Dy E, Lavalle G. Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors. Breast Cancer Res Treat. 2005;89:251-255 (Pubitemid 43293072)
48. Cohen JC, Schall R. Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals. Am J Clin Nutr. 1988;48:1031-1034 (Pubitemid 18278423)
49. Abraha A, Humphreys SM, Clark ML, Matthews DR, Frayn KN. Acute effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br J Nutr. 1998;80:169-175 (Pubitemid 28451428)
50. Singleton MJ, Heiser C, Jamesen K, Mattes RD. Sweetener augmentation of serum triacylglycerol during a fat challenge test in humans. J Am Coll Nutr. 1999;18:179-185 (Pubitemid 29157325)
51. Stark KD, Holub BJ. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr. 2004;79:765-773 (Pubitemid 41103876)
52. Frankenfeld CL, Lampe JW, Shannon J, Gao DL, Ray RM, Prunty J, Kalhorn TF, Wahala K, Patterson RE, et al. Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai. Public Health Nutr. 2004;7:765-772 (Pubitemid 39159045)
53. Orem C, Orem A, Uydu HA, Celik S, Erdol C, Kural BV. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status. Coron Artery Dis. 2002;13:65-71. (Pubitemid 34274252)
54. Kay CD, Holub BJ. The effect of wild blueberry (Vaccinium angustifolium) consumption on postprandial serum antioxidant status in human subjects. Br J Nutr. 2002;88:389-398 (Pubitemid 35251955)
55. Rufer CE, Bub A, Moseneder J, Winterhalter P, Sturtz M, Kulling SE. Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study. Am J Clin Nutr. 2008;87:1314-1323
56. Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ, Heizer WD, Thomas BF, Hill JM, et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr. 2002;75:126-136 (Pubitemid 34013498)
57. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001;131:S1362-75. (Pubitemid 32268489)
58. Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr. 2003;77:1459-1465 (Pubitemid 39655280)
59. Burdge GC, Powell J, Calder PC. Lack of effect of meal fatty acid composition on postprandial lipid, glucose and insulin responses in men and women aged 50-65 years consuming their habitual diets. Br J Nutr. 2006;96:489-500.
60. Hall WL, Sanders KA, Sanders TA, Chowienczyk PJ. A high-fat meal enriched with eicosapentaenoic acid reduces postprandial arterial stiffness measured by digital volume pulse analysis in healthy men. J Nutr. 2008;138:287-291
61. Chong MF, Fielding BA, Frayn KN. Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr. 2007;85:1511-1520 (Pubitemid 46890417)
62. Zampelas A, Peel AS, Gould BJ, Wright J, Williams CM. Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men. Eur J Clin Nutr. 1994;48:842-848
63. Harris WS, Hustvedt BE, Hagen E, Green MH, Lu G, Drevon CA. n-3 fatty acids and chylomicron metabolism in the rat. J Lipid Res. 1997;38:503-515 (Pubitemid 27166693)
64. GISSI-Prevenzione-Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455
65. Tinker LF, Parks EJ, Behr SR, Schneeman BO, Davis PA. (n-3) Fatty acid supplementation in moderately hypertriglyceridemic adults changes postprandial lipid and apolipoprotein B responses to a standardized test meal. J Nutr. 1999;129:1126-1134 (Pubitemid 29250160)
66. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-2757 (Pubitemid 35364932)
67. Rose EL, Holub BJ. Effects of a liquid egg product containing fish oil on selected cardiovascular disease risk factors: a randomized crossover trial. Food Res Int. 2006;39:910-916 (Pubitemid 44163222)
68. Campbell CG, Brown BD, Dufner D, Thorland WG. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids. 2006;41:257-265